Skip to main content
Drug Delivery logoLink to Drug Delivery
. 2019 Mar 25;26(1):1300. doi: 10.1080/10717544.2019.1594569

Correction

PMCID: PMC8670755  PMID: 30905180

Article title: ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20

Authors: Locke, K. W., Maneval, D. C., & LaBarre, M. J.

Journal: Drug Delivery

DOI: http://dx.doi.org/10.1080/10717544.2018.1551442

The article title has been changed from “ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase 20” to “ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20”


Articles from Drug Delivery are provided here courtesy of Taylor & Francis

RESOURCES